O'Shaughnessy Asset Management, LLC Fate Therapeutics Inc Transaction History

O'Shaughnessy Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$29.67 - $60.28 $133,574 - $271,380	-4,502 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$47.84 - $64.34 $9,472 - $12,739	-198 Reduced 4.21%	4,502 $263,000
Q3 2021 Nov 10, 2021	SELL	$59.27 - $95.73 $7,705 - $12,444	-130 Reduced 2.69%	4,700 $279,000
Q2 2021 Aug 09, 2021	SELL	$67.25 - $92.52 $134 - $185	-2 Reduced 0.04%	4,830 $419,000
Q1 2021 May 14, 2021	SELL	$72.16 - $117.4 $1,659 - $2,700	-23 Reduced 0.47%	4,832 $398,000
Q4 2020 Feb 11, 2021	BUY	$38.09 - $100.95 $175,214 - $464,370	4,600 Added 1803.92%	4,855 $441,000
Q2 2020 Aug 13, 2020	BUY	$20.21 - $35.23 $5,153 - $8,983	255 New	255 $9,000
Q1 2020 May 13, 2020	SELL	$17.28 - $31.88 $4,406 - $8,129	-255 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$13.39 - $20.73 $3,414 - $5,286	255 New	255 $5,000

167

101M

41.3K

15.9K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $99.9M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.